CAP-PHARMA-USP
Powder · Pharmaceutical grade
API purification, mother-liquor decolorization, excipients.
Iodine≥ 900 mg/g
Ash< 3%
Heavy metals< 10 mg/kg
Arsenic< 2 mg/kg
Productiondedicated line
Industry · Pharmaceutical & cosmetics
USP purity,batch-level traceability.
API purification, excipients, and cosmetics. Heavy metals < 10 mg/kg. Ash < 3%. Dedicated line. USP/EP roadmap with GMP audit.
Product target
Iodine
≥ 900mg/g
Ash
< 3%
Heavy met.
< 10mg/kg
pH
6–8
The regulatory decision
Change control takes six months. That is why we only offer carbon that passes audit.
Any supplier substitution in pharma manufacturing is a change-control event. The window between technical evaluation and regulatory approval is measured in months, and the cost of a recall is orders of magnitude larger than the input price.
That is why our pharmaceutical grade runs on a dedicated line, with batch documentation that matches a Qualified Person's audit. The USP/EP roadmap is published with target dates.
Recommended product
One grade, three documentation levels.
For API purification, excipients, and cosmetics, with lot-to-lot traceability.
CAG-PHARMA-CW
Granular · Process water
Purified water for pharmaceutical and injectable use.
Iodine ≥ 950 mg/gHardness ≥ 95%Ash < 3%
CAP-COSM-LT
Powder · Cosmetics
Masks, toothpastes and detoxification products.
MB ≥ 200 mg/gPass 325 ≥ 95%Ash < 4%
Applications
Four uses. Equivalent documentation.
01
API purification
Mother-liquor decolorization and catalyst residue removal.
02
Excipients & formulation
Direct incorporation into oral or topical final products.
03
Pharmaceutical water
Chloramine and TOC removal prior to purified water.
04
Cosmetics & detox
Toothpastes, masks, consumer products with pharma-grade image.
Pharmaceutical compliance
What an ANVISA, COFEPRIS, or FDA auditor requires.
USP · EP · JP
Activated carbon monograph · roadmap
GMP · cGMP
Good Manufacturing · dedicated line
ICH Q7
GMP for APIs
ANVISA · COFEPRIS
Brazil and Mexico registrations
ANMAT · INVIMA · DIGEMID
Argentina · Colombia · Peru
Next step
Receive our technical dossierfor change-control evaluation.
Includes sample CoA, analytical methods, origin declaration, and pharmaceutical certification roadmap.